id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-D-0592-0010,FDA,FDA-2008-D-0592,Contents of a Complete Submission for the Evaluation ofProprietary Names - Guidance for Industry,Other,Guidance,2010-02-12T05:00:00Z,2010,2,2010-02-08T05:00:00Z,,2020-04-21T15:30:22Z,,0,0,0900006480a92059
FDA-2008-D-0592-0009,FDA,FDA-2008-D-0592,Guidance for Industry: Contents of Complete Submission for Evaluation of Proprietary Names; Availability,Notice,Notice of Availability,2010-02-08T05:00:00Z,2010,2,2010-02-08T05:00:00Z,,2020-04-21T15:30:43Z,2010-02660,0,0,0900006480a8fa37